Radiopharmaceuticals Market Poised to Register 5.3% CAGR Through 2024
The radiopharmaceutical market is highly consolidated, wherein the top two players ?€" Siemens Healthineers and GE Healthcare ?€" jointly accounted for over 70% of the global market in 2015. Transparency Market Research has observed that the degree of competition is rather high in the market owing to the presence of key players with the availability of advanced technologies and potential productive sources and a high product manufacturing capacity.
View full press release